Sigma-Tau Pharmaceuticals
Sigma-Tau Pharmaceuticals (Italy) has no DMF, CEP or site registration linked in our records. 3 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Sigma-Tau Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sigma-tau-pharmaceuticals
Overview
Sigma-Tau Pharmaceuticals is a private pharmaceutical company focused on the development and commercialization of therapies for rare and orphan diseases. With a strong commitment to innovation, Sigma-Tau is dedicated to advancing treatment options that improve patient outcomes.
Therapeutic areas
FDA compliance signals
3 FDA enforcement records linked to this company.
- recall — Class II2014-01-22
Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.
- 4832008-10-16
Timely submission
- 4832008-10-16
Late submission of annual safety reports
Is this Sigma-Tau Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.